Humana Logo

Humana

ISIN: SE0008040653 | Ticker: HUM | LEI: 549300A5X3MXUDS67N81
Sector: Health CareSub-Industry: Health Care Facilities
Country: Sweden

About Humana

Company Description

Humana is a leading Nordic care company offering services within individual and family care, personal assistance, elderly care and housing with special services according to LSS.

Humana has around 16,000 dedicated employees in Sweden, Norway, Finland and Denmark who provide care services to 9,000 people. We work according to the vision "Everyone has the right to a good life".
In 2018, operating income amounted to SEK 6,725 million. Humana has been listed on Nasdaq Stockholm since 2016 and is headquartered in Stockholm.

Headquarters

Warfvinges väg 39, 7tr, 11251 Stockholm – Sweden

Financial statements

Download as Excel
Line item in (sek) 01.01.2020 01.01.2021 02.01.2021 01.01.2022 02.01.2022 01.01.2023
Assets N/A 8,044,000,000.00 N/A 9,002,000,000.00 N/A 9,806,000,000.00
Noncurrent Assets N/A 6,295,000,000.00 N/A 7,243,000,000.00 N/A 7,899,000,000.00
Property Plant And Equipment N/A 314,000,000.00 N/A 360,000,000.00 N/A 464,000,000.00
Goodwill N/A 3,815,000,000.00 N/A 4,148,000,000.00 N/A 4,409,000,000.00
Intangible Assets Other Than Goodwill N/A 5,000,000.00 N/A 11,000,000.00 N/A 40,000,000.00
Deferred Tax Assets N/A 28,000,000.00 N/A 41,000,000.00 N/A 39,000,000.00
Current Assets N/A 1,749,000,000.00 N/A 1,759,000,000.00 N/A 1,907,000,000.00
Trade And Other Current Receivables N/A 991,000,000.00 N/A 1,064,000,000.00 N/A 1,217,000,000.00
Current Trade Receivables N/A 852,000,000.00 N/A 923,000,000.00 N/A 1,026,000,000.00
Other Current Receivables N/A 9,000,000.00 N/A 7,000,000.00 N/A 16,000,000.00
Current Tax Assets Current N/A 68,000,000.00 N/A 70,000,000.00 N/A 106,000,000.00
Cash and cash equivalents 836,000,000.00 759,000,000.00 759,000,000.00 695,000,000.00 695,000,000.00 690,000,000.00
Equity And Liabilities N/A 8,044,000,000.00 N/A 9,002,000,000.00 N/A 9,806,000,000.00
Equity 2,305,000,000.00 2,354,000,000.00 2,354,000,000.00 2,553,000,000.00 2,553,000,000.00 2,739,000,000.00
Issued Capital N/A 1,000,000.00 N/A 1,000,000.00 N/A 1,000,000.00
Retained Earnings N/A 1,264,000,000.00 N/A 1,436,000,000.00 N/A 1,592,000,000.00
Other Reserves N/A -6,000,000.00 N/A 21,000,000.00 N/A 50,000,000.00
Additional Paidin Capital N/A 1,096,000,000.00 N/A 1,096,000,000.00 N/A 1,096,000,000.00
Equity Attributable To Owners Of Parent N/A 2,354,000,000.00 N/A 2,553,000,000.00 N/A 2,739,000,000.00
Noncontrolling Interests N/A N/A N/A 0.00 N/A 0.00
Noncurrent Liabilities N/A 3,527,000,000.00 N/A 4,780,000,000.00 N/A 5,056,000,000.00
Deferred Tax Liabilities N/A 70,000,000.00 N/A 74,000,000.00 N/A 58,000,000.00
Longterm Borrowings N/A 1,499,000,000.00 N/A 2,146,000,000.00 N/A 2,263,000,000.00
Current Liabilities N/A 2,163,000,000.00 N/A 1,669,000,000.00 N/A 2,011,000,000.00
Trade And Other Current Payables To Trade Suppliers N/A 128,000,000.00 N/A 165,000,000.00 N/A 187,000,000.00
Other Current Payables N/A 257,000,000.00 N/A 279,000,000.00 N/A 299,000,000.00
Line item in (sek) 01.01.2020/
01.01.2021
01.01.2021/
01.01.2022
01.01.2022/
01.01.2023
Revenue 7,771,000,000.00 8,176,000,000.00 9,199,000,000.00
Other Income 26,000,000.00 12,000,000.00 42,000,000.00
Employee Benefits Expense 6,039,000,000.00 6,333,000,000.00 7,253,000,000.00
Depreciation Amortisation And Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss 371,000,000.00 420,000,000.00 457,000,000.00
Other Expense By Nature 2,000,000.00 16,000,000.00 10,000,000.00
Profit Loss From Operating Activities 471,000,000.00 493,000,000.00 439,000,000.00
Finance Income 6,000,000.00 4,000,000.00 24,000,000.00
Finance Costs 145,000,000.00 143,000,000.00 189,000,000.00
Profit Loss Before Tax 332,000,000.00 354,000,000.00 274,000,000.00
Income Tax Expense Continuing Operations 70,000,000.00 78,000,000.00 64,000,000.00
Profit (loss) 262,000,000.00 276,000,000.00 210,000,000.00
Profit Loss Attributable To Owners Of Parent 262,000,000.00 276,000,000.00 210,000,000.00
Profit Loss Attributable To Noncontrolling Interests N/A 0.00 0.00
Line item in (sek) 01.01.2020 01.01.2021 01.01.2022 02.01.2021 01.01.2023 02.01.2022
Profit (loss) N/A 262,000,000.00 276,000,000.00 N/A 210,000,000.00 N/A
Adjustments For Finance Costs N/A 145,000,000.00 143,000,000.00 N/A 179,000,000.00 N/A
Adjustments For Decrease Increase In Other Operating Receivables N/A 22,000,000.00 -21,000,000.00 N/A -16,000,000.00 N/A
Adjustments For Increase Decrease In Trade Account Payable N/A 16,000,000.00 32,000,000.00 N/A 9,000,000.00 N/A
Adjustments For Increase Decrease In Other Operating Payables N/A 54,000,000.00 11,000,000.00 N/A 93,000,000.00 N/A
Other Adjustments For Noncash Items N/A 0.00 -4,000,000.00 N/A -3,000,000.00 N/A
Adjustments For Losses Gains On Disposal Of Noncurrent Assets N/A N/A 2,000,000.00 N/A 1,000,000.00 N/A
Cash Flows From Used In Operations N/A 895,000,000.00 900,000,000.00 N/A 867,000,000.00 N/A
Interest Paid Classified As Operating Activities N/A 144,000,000.00 140,000,000.00 N/A 165,000,000.00 N/A
Interest Received Classified As Operating Activities N/A 1,000,000.00 1,000,000.00 N/A 7,000,000.00 N/A
Cash Flows From Used In Operating Activities N/A 661,000,000.00 689,000,000.00 N/A 633,000,000.00 N/A
Cash Flows From Losing Control Of Subsidiaries Or Other Businesses Classified As Investing Activities N/A N/A 0.00 N/A -1,000,000.00 N/A
Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities N/A 18,000,000.00 153,000,000.00 N/A 71,000,000.00 N/A
Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities N/A 114,000,000.00 5,000,000.00 N/A 9,000,000.00 N/A
Cash Flows From Used In Investing Activities N/A -37,000,000.00 -260,000,000.00 N/A -246,000,000.00 N/A
Payments To Acquire Or Redeem Entitys Shares N/A 156,000,000.00 159,000,000.00 N/A 55,000,000.00 N/A
Proceeds From Borrowings Classified As Financing Activities N/A 24,000,000.00 1,489,000,000.00 N/A 0.00 N/A
Repayments Of Borrowings Classified As Financing Activities N/A 251,000,000.00 1,540,000,000.00 N/A 2,000,000.00 N/A
Payments Of Lease Liabilities Classified As Financing Activities N/A 284,000,000.00 312,000,000.00 N/A 368,000,000.00 N/A
Cash Flows From Used In Financing Activities N/A -667,000,000.00 -521,000,000.00 N/A -424,000,000.00 N/A
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes N/A -42,000,000.00 -92,000,000.00 N/A -38,000,000.00 N/A
Effect Of Exchange Rate Changes On Cash And Cash Equivalents N/A -35,000,000.00 28,000,000.00 N/A 32,000,000.00 N/A
Cash and cash equivalents 836,000,000.00 759,000,000.00 695,000,000.00 759,000,000.00 690,000,000.00 695,000,000.00

Please note that some sums might not add up.

Filings & Publications

2022

Report
Q1
H1
Q3
FY
Consolidated Report
SWE
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2021

Report
Q1
H1
Q3
FY
Consolidated Report
ENG / SWE
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

Insider Trades

Date Trading entity / Person Association Trade type Volume
09.08.23 Fredrik Strömholm Other Buy SEK 8,580,000.00
08.08.23 Fredrik Strömholm Other Buy SEK 2,261,872.00
14.02.23 Anders Nyberg Other Buy SEK 196,170.00
02.01.23 Fredrik Strömholm Other Buy SEK 388,750.00
09.09.22 Fredrik Strömholm Other Buy SEK 1,050,939.58
08.09.22 Fredrik Strömholm Other Buy SEK 173,505.00
07.09.22 Fredrik Strömholm Other Buy SEK 376,268.47
06.09.22 Fredrik Strömholm Other Buy SEK 74,620.44
05.09.22 Fredrik Strömholm Other Buy SEK 61,559.99
02.09.22 Fredrik Strömholm Other Buy SEK 151,027.82

Capital markets information

ISIN

SE0008040653

LEI

549300A5X3MXUDS67N81

Sector

Health Care

Industry Group

Health Care Equipment & Services

Industry

Health Care Providers & Services

Sub-Industry

Health Care Facilities

Listed Stock Exchange

Nasdaq Stockholm

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.